RET fusion genes in non-small-cell lung cancer.

Suppr

超能文献

作者信息

Chao Bo H, Briesewitz Roger, Villalona-Calero Miguel A

机构信息

The Ohio State University, Columbus, OH, USA.

出版信息

J Clin Oncol. 2012 Dec 10;30(35):4439-41. doi: 10.1200/JCO.2012.45.8240. Epub 2012 Nov 13.

DOI:10.1200/JCO.2012.45.8240

PMID:23150705

Abstract

摘要

相似文献

RET fusion genes in non-small-cell lung cancer.

J Clin Oncol. 2012 Dec 10;30(35):4439-41. doi: 10.1200/JCO.2012.45.8240. Epub 2012 Nov 13.

Gene fusion implicated in lung cancer occurrence.

Expert Rev Proteomics. 2012;9(1):6.

FRMD4A/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma.

J Thorac Oncol. 2017 Feb;12(2):e15-e16. doi: 10.1016/j.jtho.2016.11.274.

WAC/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma.

J Thorac Oncol. 2018 Jul;13(7):e122-e123. doi: 10.1016/j.jtho.2018.03.003.

[The progress of KIF5B-RET fusion gene in non-small cell lung cancer].

Zhonghua Jie He He Hu Xi Za Zhi. 2013 Jul;36(7):524-6.

FDA Approves Pralsetinib for Treatment of Adults With Metastatic RET Fusion-Positive NSCLC.

Oncology (Williston Park). 2020 Oct 9;34(10):406-406;431. doi: 10.46883/ONC.2020.3410.0406.

A mass spectrometry assay to simultaneously analyze ROS1 and RET fusion gene expression in non-small-cell lung cancer.

J Thorac Oncol. 2015 Feb;10(2):381-6. doi: 10.1097/JTO.0000000000000337.

A Novel Oncogenic RET Fusion Variant in Non-Small Cell Lung Cancer: RELCH-RET.

J Thorac Oncol. 2020 Feb;15(2):e27-e28. doi: 10.1016/j.jtho.2019.08.2510.

[Significances of RET fusion gene in non-small cell lung cancer].

Zhongguo Fei Ai Za Zhi. 2013 Nov;16(11):615-20. doi: 10.3779/j.issn.1009-3419.2013.11.11.

[Personalized medicine in non-small-cell carcinoma].

Fukuoka Igaku Zasshi. 2014 Mar;105(3):57-66.

引用本文的文献

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC.

Front Oncol. 2024 Feb 7;14:1307458. doi: 10.3389/fonc.2024.1307458. eCollection 2024.

RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy.

Cancers (Basel). 2022 Oct 27;14(21):5298. doi: 10.3390/cancers14215298.

Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2.

Front Mol Biosci. 2022 Aug 23;9:952651. doi: 10.3389/fmolb.2022.952651. eCollection 2022.

The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients.

J Cancer Res Clin Oncol. 2023 Mar;149(3):1019-1028. doi: 10.1007/s00432-022-03959-6. Epub 2022 Feb 26.

Targeted Therapy For RET-Rearranged Non-Small Cell Lung Cancer: Clinical Development And Future Directions.

Onco Targets Ther. 2019 Sep 24;12:7857-7864. doi: 10.2147/OTT.S171665. eCollection 2019.

Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors.

Oncotarget. 2019 Mar 12;10(21):2095-2111. doi: 10.18632/oncotarget.26777.

Targeting RET-rearranged non-small-cell lung cancer: future prospects.

Lung Cancer (Auckl). 2019 Mar 20;10:27-36. doi: 10.2147/LCTT.S192830. eCollection 2019.

A novel computational approach for drug repurposing using systems biology.

Bioinformatics. 2018 Aug 15;34(16):2817-2825. doi: 10.1093/bioinformatics/bty133.

Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancer.

Ann Transl Med. 2017 Sep;5(18):372. doi: 10.21037/atm.2017.08.42.

Familial risk for lung cancer.

Oncol Lett. 2017 Feb;13(2):535-542. doi: 10.3892/ol.2016.5518. Epub 2016 Dec 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验